Alan Sobel D.'s most recent trade in Cytosorbents Corp was a trade of 21,950 Series A Right Warrants (right to buy) done . Disclosure was reported to the exchange on Feb. 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cytosorbents Corp | Alan D. Sobel | Director | 24 Feb 2025 | 21,950 | 0 | - | - | Series A Right Warrants (right to buy) | ||
| Cytosorbents Corp | Alan D. Sobel | Director | 24 Feb 2025 | 21,950 | 145,757 (0%) | 0% | 1.1 | 24,804 | Common Stock | |
| Cytosorbents Corp | Alan D. Sobel | Director | 17 Jan 2025 | 21,950 | 123,807 (0%) | 0% | 1 | 21,950 | Common Stock | |
| Cytosorbents Corp | Alan D. Sobel | Director | 17 Jan 2025 | 21,950 | 0 | - | - | Subscription Rights (right to buy) | ||
| Cytosorbents Corp | Alan D. Sobel | Director | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 21,950 | 21,950 | - | - | Series A Right Warrants | |
| Cytosorbents Corp | Alan D. Sobel | Director | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 21,950 | 21,950 | - | - | Series B Right Warrants | |
| Cytosorbents Corp | Alan D. Sobel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Cytosorbents Corp | D. Alan Sobel | Director | Purchase of securities on an exchange or from another person at price $ 1.33 per share. | 13 Dec 2023 | 22,557 | 101,857 (0%) | 0% | 1.3 | 30,001 | Common Stock |
| Cytosorbents Corp | Alan Sobel D. | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Dec 2023 | 7,894 | 7,894 | - | - | Common Stock Warrant (Right to Buy) | |
| Cytosorbents Corp | Alan D. Sobel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Cytosorbents Corp | Alan D. Sobel | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Feb 2023 | 2,000 | 0 (0%) | 0% | 0 | Common Stock | |
| Cytosorbents Corp | Alan D. Sobel | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Feb 2023 | 2,000 | 81,300 (0%) | 0% | 0 | Common Stock | |
| Cytosorbents Corp | Alan D. Sobel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 18,975 | 18,975 | - | - | Stock Option (right to buy) | |
| Cytosorbents Corp | Alan D. Sobel | Director | Purchase of securities on an exchange or from another person at price $ 2.02 per share. | 11 May 2022 | 8,800 | 79,300 (0%) | 0% | 2.0 | 17,776 | Common Stock |
| Cytosorbents Corp | Alan D. Sobel | Director | Purchase of securities on an exchange or from another person at price $ 2.00 per share. | 11 May 2022 | 1,200 | 70,500 (0%) | 0% | 2.0 | 2,399 | Common Stock |
| Cytosorbents Corp | Alan D. Sobel | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Feb 2022 | 2,000 | 2,000 (0%) | 0% | 0 | Common Stock | |
| Cytosorbents Corp | Alan D. Sobel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 17,250 | 17,250 | - | - | Stock Option (right to buy) |